A retrospective analysis of efficacy and safety of adding bevacizumab to chemotherapy as first- and second-line therapy in advanced non-small-cell lung cancer (NSCLC).
about
A retrospective analysis of efficacy and safety of adding bevacizumab to chemotherapy as first- and second-line therapy in advanced non-small-cell lung cancer (NSCLC).
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
A retrospective analysis of ef ...... mall-cell lung cancer (NSCLC).
@ast
A retrospective analysis of ef ...... mall-cell lung cancer (NSCLC).
@en
type
label
A retrospective analysis of ef ...... mall-cell lung cancer (NSCLC).
@ast
A retrospective analysis of ef ...... mall-cell lung cancer (NSCLC).
@en
prefLabel
A retrospective analysis of ef ...... mall-cell lung cancer (NSCLC).
@ast
A retrospective analysis of ef ...... mall-cell lung cancer (NSCLC).
@en
P2093
P2860
P1433
P1476
A retrospective analysis of ef ...... mall-cell lung cancer (NSCLC).
@en
P2093
Hongyu Zhang
Jianhua Zhan
Jiaxing Huang
Rencui Quan
Wenfeng Fang
Zhihuang Hu
P2860
P2888
P304
11479-11484
P356
10.1007/S13277-016-5031-0
P577
2016-03-25T00:00:00Z
P6179
1028545463